Delivery Order SPE2DB20D1004-SPE2DB23FE8G7
Award Date
11/4/22
Potential Completion Date
11/7/22
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FS10B) worth $18,345.92 for the pharmaceutical product Xeljanz XR 11 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on March 16, 2022, with a completion date of March 17, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,650.81 firm fixed-price delivery order is for the supply of the pharmaceutical drug Xeljanz XR 11 mg tablets. The award has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,004.76 firm fixed-price delivery order, awarded on May 3, 2024, has an ultimate completion date of May 6, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the agency's Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,018.34 delivery order contract is for the supply of Xeljanz XR 11 mg tablets to support military and veterans' healthcare programs. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., and has established itself as a key vendor for the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at $3,738.19, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. The contract covers the delivery of Xeljanz 5 mg tablets, a specialty medication, with a performance period through September 19, 2023....
This federal contract award is from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $27,526.76, is for the delivery of Xeljanz XR 11 mg tablets. This is a firm fixed-price delivery order contract with a completion date of February 12, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has an award value of $4,550.58. It is a delivery order contract with a firm fixed price pricing type, awarded by the Defense Logistics Agency (DLA) for the procurement of XELJANZ XR 11 MG TABLET. The contract has an ultimate completion date of May 24, 2024. While this contract does not have a set-aside designation, AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $35,474.99 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG Tablets, a pharmaceutical product, to support military and government healthcare programs. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $15,517.68 for the supply of XELJANZ XR 11 MG TABLET. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 5, 2023. The contract type is firm fixed price. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...